Validation de l'échelle d'évaluation des comportements et des attitudes d'observance des prescriptions psychopharmacologiques (ÉCAOPP)

Canadian Journal of Behavioural Science

Volumn 39, Issue 4, 2007, Pages 326-338

  Laurier, Catherine ^a   Lafortune, Denis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37149050217     PISSN: 0008400X     EISSN: None     Source Type: Journal    
DOI: 10.1037/cjbs2007026     Document Type: Article

References (54)

1. Baillargeon, J., Contreras, S., Grady, J. J., Black, S. A., & Murray, O. (2000). Compliance with antidepressant medication among prison inmates with depressive disorders. Psychiatric Services, 51, 1444-1446.
2. Bastiaens, L. (1992a). Knowledge, expectations, and attitudes of hospitalized children and adolescents in psychopharmacological treatment. Journal of Child and Adolescent Psychopharmacology, 2, 157-171.
3. Bastiaens, L. (1992b). The impact of an intensive educational program on knowledge, attitudes, and side effects of psychotropic medications among adolescent inpatients. Journal of Child and Adolescent Psychopharmacology, 2, 249-258.
4. Bastiaens, L. (1995). Compliance with pharmacotherapy in adolescents: Effects of patients' and parents' knowledge and attitudes toward treatment. Journal of Child and Adolescent Psychopharmacology, 5, 39-48.
5. Bastiaens, L., Chowdhury, S., & Gitelman, L. (2000). Medication samples and drug compliance. Psychiatric Services, 51, 819.
6. Baumann, M., & Trincard, M. (2002). Les attitudes d'autonomie dans l'observance thérapeutique d'une cohorte de consommateurs continues de psychotropes. Encephale, 28(5 Pt 1), 389-396.
7. Becker, M. H., & Mainman, L. A. (1975). Sociobehavioral determinants of compliance with health and medical care recommendations. Medical Care, 13(1), 10-24.
8. Bourgeois, J. A. (2005). Compliance with psychiatric treatment in primary care: Review and strategies. Primary Psychiatry, 12, 40-47.
9. Bowen, J., Fenton, T., & Rappaport, L. (1991). Stimulant medication and attention deficit-hyperactivity disorder. The child's perspective. American Journal of Diseases of Children, 145, 291-295.
10. Bradlew, S. S. (2003). The psychology of psychopharmacology triangle: The client, the clinicians and the medication. Social Work in Mental Health, 1(4), 29-50.
11. Bush, P. J., & Iannotti, R. J. (1990). A Children's health belief model. Medical Care, 28, 69-86.
12. Chappuy, H., Tréluyer, J.-M., Gary, A., Pons, G., & Chéron, G. (2005). Observance médicamenteuse chez l'enfant. Archives de pédiatrie, 12, 921-923.
13. Conrad, P. (1985). The meaning of medications: Another look at compliance. Social Sciences and Medicine, 20(1), 29-37.
14. Cook, C. L., & Perri, M., III (2004). Single-item vs. multiple-item measures of stage of change in compliance with prescribed medications. Psychological Report, 94, 115-124.
15. Cramer, J. A., & Rosenheck, R. (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196-201.
16. DiClemente, C. C., & J. O. Prochaska (1982). Self-change and therapy change of smoking behavior: A comparison of processes of change in cessation and maintenance. Addictive Behaviors, 7, 133-142.
17. DiMatteo, M. R. (1994). Enhancing patient adherence to medical recommendations. Journal of the American Medical Association, 271, 79.
18. Dixon, L., Weiden, P., Torres, M., & Lehman, A. (1997). Assertive community treatment and medication compliance in the homeless mentally ill. American Journal of Psychiatry, 154, 1302-1304.
19. DosReis, S., Zito, J. M., Safer, D. J., & Soeken, K. L. (2001). Mental health services for youths in foster care and disabled youths. American Journal of Public Health, 91, 1094-1099.
20. DosReis, S., Zito, J. M., Safer, D. J., Soeken, K. L., Mitchell, J. W., Jr., & Ellwood, L. C. (2003). Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 24(3), 155-162.
21. Ellis, S., Shumaker, S., Sieber, W., & Rand, C. (2000). Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group. Controlled Clinical Trials, 21(5Suppl.), 218S-225S.
22. Ghaziuddin, N., King, C. A., Hovey, J. O., Zaccagnini, J., & Ghaziuddin, M. (1999). Medication noncompliance in adolescents with psychiatric disorders. Child Psychiatry and Human Development, 30, 103-110.
23. Gordis, L. (1976). Methodologic issues in the measurment of patient compliance. Dans D. Sackett et R. B. Haynes R. B. (Éds.). Compliance with Therapeutic Regimens (p. 51-66). Baltimore, MD: Johns Hopkins University Press.
24. Grasset, F., Bonvin, E., & Pomini, V. (2000). Pharmacothérapie psychotrope, compliance au traitement et observance des prescriptions. Revue médicale de la Suisse Romande, 120, 137-143.
25. Greenhill, L. L., & Setterberg, S. (1993). Pharmacotherapy of disorders of adolescents. Psychiatrie Clinics of North America, 16, 793-814.
26. Hack, S., & Chow, B. (2001). Pediatric psychotropic medication compliance: a literature review and researchbased suggestions for improving treatment compliance. Journal of Child and Adolescent Psychopharmacology, 11, 59-67.
27. Haynes, R. B. (1979). Introduction. Dans R. B. Haynes, D. W. Taylor, et D. L. Sackett (Éds.), Compliance in Health Care (p. 1-7). Baltimore, MD: Johns Hopkins University Press.
28. Haynes, R. B., Taylor, D. W., & Sackett, D. L. (Éds.) (1979). Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press, 516 p.
29. Holzinger, A., Loffler, W., Muller, P., Priebe, S., & Angermeyer, M. C. (2002). Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia. Journal of Nervous and Mental Diseases, 190, 597-603.
30. Horne, R., & Weinman, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555-567.
31. Lafortune, D., Laurier, C., & Gagnon, F. (2004). Prévalence et facteurs associés à la prescription de médicaments psychotropes chez les sujets placés en Centre Jeunesse. Revue de psychoéducation, 33, 157-176.
32. Laurier, C., & Lafortune, D. (sous presse). Les facteurs contribuant à l'observance d'une psychopharmacothérapie chez les adolescents hébergés en centres de réadaptation. Revue canadienne de psychologie.
33. Leo, R. J., Jassal, K., & Bakhai, Y. D. (2005). Nonadherence with psychopharmacologic treatment among psychiatric patients. Primary Psychiatry, 12, 33-39.
34. Lerner, B. H. (1997). From careless consumptives to recalcitrant patients: The historical construction of non-compliance. Social Sciences and Medicine, 45, 1423-1431.
35. Lloyd, A., Horan, W., Borgaro, S. R., Stokes, J. M., Pogge, D. L., & Harvey, P. D. (1998). Predictors of medication compliance after hospital discharge in adolescent psychiatric patients. Journal of Child and Adolescent Psychopharmacology, 8, 133-141.
36. McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientific review. Journal of the American Medical Association, 288, 2868-2879.
37. Meichenbaum, D., & Turk, D. C. (1987). Facilitating treatment adherence. New York: Plenum Press.
38. Mercier, C. (1989). Le rôle des facteurs subjectifs dans la fidélité à la médication. Revue canadienne de psychiatrie, 34, 662-667.
39. Morris, M. (1996). Patients' perceptions of psychiatric home care. Archives of Psychiatrie Nursing, 10, 176-183.
40. Nichol, M. B., Venturini, F., & Sung., J. C. (1999). A critical evaluation of the methodology of the literature on medication compliance. Annals of Pharmacotherapy, 33(5), 531-540.
41. Pampailona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2002). Patient adherence in the treatment of depression. British Journal of Psychiatry, 180, 104-109.
42. Ross, F. M. (1991). Patient compliance - Whose responsibility? Social Sciences and Medicine, 32, 89-94.
43. Sackett, D. L. (1976). The magnitude of compliance and noncompliance. Dans D. Sackett et R. B. Haynes (Éds.). Compliance with Therapeutic Regimens, (p. 9-25). Baltimore et Londres : Johns Hopkins University Press.
44. Sher, I., McGinn, L., Sirey, J., & Meyers, B. (2005). Effets of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment. Psychiatric Services, 56, 564-569.
45. Sleath, B., Roter, D., Chewning, B., & Svarstad, B. (1999).Asking questions about medication: Analysis of physician-patient interactions and physician perceptions. Medical Care, 37(11), 1169-1173.
46. Sleator, E. K. (1985). Measurement of compliance. Psychopharmacology Bulletin, 21, 1089-1093.
47. Steiner, J. F., & Prochazka, A. V. (1997). The assessment of refill compliance using pharmacy records: Methods, validity, and applications. Journal of Clinical Epidemiology, 50, 105-116.
48. Thiruchelvam, D., Charach, A., & Schachar, R. J. (2001). Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 40(8), 922-928.
49. Trostle, J. A., (1998). Medical compliance as an ideology. Social Sciences and Medicine, 27(12), 1299-1308.
50. Van De Geest, S., Renteln-Kruse, W. v., Steeman, E., Degraeve, S., & Abraham, I. L. (1998). Compliance issues with the geriatric population. Nursing Clinics of North America, 33, 467-480.
51. Vitolins, M. Z., Rand, C. S., Rapp, S. R., Ribisl, P. M., & Sevick, M. A. (2000). Measuring adherence to behavioral and medical interventions. Controlled Clinical Trials, 21(5 Suppl), 188S-194S.
52. Williams, R. A., Mollis, H. M., & Benoit, K. (1998). Attitudes toward psychiatric medications among incarcerated female adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1301-1307.
53. Zima, B. T., Bussing, R., Crecelius, G. M., Kaufman, A., & Belin, T. R. (1999). Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders. American Journal of Public Health, 89, 1732-1735.
54. Zito, J. M., Safer, D. J., DosReis, S., & Riddle, M. A. (1998). Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 179-184.